These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 14560161

  • 21. Whose TPMT activity is it anyway?
    Ford L, Prout C, Gaffney D, Berg J.
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):498-500. PubMed ID: 15588444
    [Abstract] [Full Text] [Related]

  • 22. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
    Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA.
    J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
    [Abstract] [Full Text] [Related]

  • 23. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
    Arenas M, Duley JA, Ansari A, Shobowale-Bakre EA, Fairbanks L, Soon SY, Sanderson J, Marinaki AM.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
    [Abstract] [Full Text] [Related]

  • 24. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP, Liang LQ, Yang XY, Wang YX, Huang M, Li H.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 03; 87(25):1734-7. PubMed ID: 17919375
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM.
    Clin Gastroenterol Hepatol; 2004 May 03; 2(5):410-7. PubMed ID: 15118980
    [Abstract] [Full Text] [Related]

  • 27. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.
    Clin Gastroenterol Hepatol; 2008 Jun 03; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [Abstract] [Full Text] [Related]

  • 28. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U, Lyrenäs E, Nilsson A, Schmiegelow K.
    Scand J Gastroenterol; 2004 Nov 03; 39(11):1105-12. PubMed ID: 15545169
    [Abstract] [Full Text] [Related]

  • 29. Fatal myelotoxicity after azathioprine treatment.
    Slanar O, Chalupná P, Novotný A, Bortlík M, Krska Z, Lukás M.
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun 03; 27(6):661-5. PubMed ID: 18600523
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
    Liu YP, Xu HQ, Li M, Yang X, Yu S, Fu WL, Huang Q.
    PLoS One; 2015 Jun 03; 10(12):e0144234. PubMed ID: 26633017
    [Abstract] [Full Text] [Related]

  • 34. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
    Ansari A, Arenas M, Greenfield SM, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):973-83. PubMed ID: 18616518
    [Abstract] [Full Text] [Related]

  • 35. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM.
    Intern Med J; 2005 Oct 15; 35(10):580-5. PubMed ID: 16207256
    [Abstract] [Full Text] [Related]

  • 36. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
    Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, Meenan J, Yim A, Sanderson J.
    Aliment Pharmacol Ther; 2002 Oct 15; 16(10):1743-50. PubMed ID: 12269967
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.
    Pharmacogenetics; 2002 Aug 15; 12(6):429-36. PubMed ID: 12172211
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease.
    Regueiro M, Mardini H.
    J Clin Gastroenterol; 2002 Sep 15; 35(3):240-4. PubMed ID: 12192200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.